Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare

Food and Healthcare Press Releases Thursday September 20, 2018 14:05
AMSTERDAM--20 Sep--PRNewswire-FirstCall/InfoQuest

Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report " Moving data to the heart of health systems: Increasing vital technology adoption to make value-based healthcare a reality ." The research focused on two technology enablers that have the potential to advance integration, and enable data to be used more effectively. Digital identity tools, such as Electronic Health Records (EHRs), based on standardized data and protocols that can be accessed, used and updated by care providers across the health continuum, can make the collection and exchange of healthcare data much easier. Data analytics and AI can mine that data for connections and insights that will benefit both healthcare professionals and patients. This ranges from the identification of health trends at the level of an entire population, to more precise diagnosis, treatment and after care for individual patients.

The latest FHI report identifies the following key recommendations for the way in which health data is collected, shared and used, in order for countries to meet their goals of driving better value in healthcare:

  • Strike the right balance in data protection and (de)regulation
  • Foster adoption through education - only 47% of healthcare professionals surveyed and 24% of the general population felt knowledgeable about connected care technologies
  • Secure buy-in through co-creation of solutions together with healthcare professionals and the general population
  • Harmonize data collection and use practices - countries with universal EHRs have a higher   Value Measure than countries without universal EHRs (47.29 on average vs 39.67), as well as higher average levels of trust (67.79 vs. 62.99)

"The   Future Health Index's latest report shows that the smooth exchange of health information is central to delivering better value in healthcare," said Jan Kimpen, Chief Medical Officer for Philips. "By connecting people, data and systems we can create a network that allows information to flow seamlessly across care providers, locations and systems. It is through data that the outcomes that define value are tracked, measured and improved. Yet, health systems around the world are still struggling to collect, organize, analyze and use health data in a meaningful way. The recommendations made in the FHI are designed to address these very challenges and provide actionable next steps that healthcare leaders can take to optimize the value provided by the digital tools they are investing in."

FHI is a research-based platform designed to help determine the readiness of countries to address global health challenges and build sustainable, fit-for-purpose national health systems. Using the real-life learning of experts in the field, and insights uncovered in research, the FHI provides actionable recommendations for the healthcare industry; particularly around the adoption and implementation of crucial digital tools that can deliver more affordable, integrated and sustainable care. A key finding of the FHI is that integrating connected care technology into health systems can accelerate countries along the path to value-based healthcare.

To download the Future Health Index 2018 report in its entirety, please visit: https://www.futurehealthindex.com/report/2018/part-2-moving-data-to-the-heart-of-health-systems . For additional Future Health Index related content, please visit https://www.futurehealthindex.com/ .

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 75,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter .

For further information, please contact:
Elena Calamo Specchia
Philips Group Press Office
Tel.: +31-6-25004735
E-mail: Elena.Calamo.Specchia@philips.com
Source: Royal Philips

Latest Press Release

Menicon Announces Launch of Menicon Bloom Myopia Control Management System

- Launch Features Initial Introduction of Menicon Bloom Night, First and Only CE-approved Orthokeratology Contact Lens in Europe for Myopia Control - Menicon Co., Ltd. announced on May 24 the launch of the Menicon Bloom Myopia Control Management System,...

Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event

- Global health leaders covered biomanufacturing and neglected tropical diseases (NTDs) during 72nd World Health Assembly - Event focused on innovative science and technology-based solutions to increase access to medicines and biologics Merck, a...

Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology

Menarini Ricerche will present three different projects related to the compounds in clinical development SEL24/MEN1703, MEN1611 and MEN1309/OBT076 at the ASCO Annual Meeting 2019 in Chicago. During the poster session "Breast Cancer – Metastatic"...

Surgical Specialties Corporation Launches Caliber Ophthalmics Division to Focus on Global Growth of Ophthalmic Surgical Procedures

Surgical Specialties Corporation (SSC) announced today the launch of Caliber Ophthalmics, a new business division. Caliber Ophthalmics combines SSC's Sharpoint(TM) brand, which has earned a trusted reputation serving ophthalmic surgeons for over 50...

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

Ori Yehudai: "I took a company worth $3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants, and...

Related Topics